$3500 | Single User
$5385 | Site License
$8300 | Enterprise License

Bioabsorbable Scaffolds - Current and Future Players
[Lowest Price Guaranteed: $3,500]

Published by Global Data: 01 Aug 2015 | 27811 | In Stock
Related Topics: Stent

Introduction

Bioabsorbable Scaffolds - Current and Future Players

Summary

Coronary artery disease (CAD) and peripheral artery disease (PAD) are global public health and socioeconomic issues that affect millions of lives each year. Bioabsorbable scaffolds (BAS), which provide transient support to the vessel, are viable alternatives to permanent drug-eluting stents (DES) and bare metal stents (BMS) implants. In the report, BAS are defined as fully-bioabsorbable devices that are used in stenting procedures that completely disappear from the target vessel overtime. Stents such as BioMatrix Flex by Biosensors International and Synergy by Boston Scientific Corporation are not included in the report because they are metallic DES with bioabsorbable polymer coatings. Absorption of the bioabsorbable polymer coating still leaves behind a permanent BMS inside the vessel.

The report provides up-to-date information and in-depth analysis on the key players that shape the global bioabsorbable scaffolds market. The report includes an analysis of company profiles, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources, primary research interviews with leading cardiovascular experts, and in-house analysis conducted by GlobalData’s team of industry experts.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Benefits

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Scope

- Investigation of current and future market competition for advanced wound dressings.

- Competitive Assessment including product profiles.

- Coverage of key market players, which includes company profiles, business descriptions, financial overviews, portfolio assessments, and SWOT analyses.

- Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

- Gain a high level view of the trends shaping and driving the Bioabsorbable Scaffolds market.

- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.

- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

Table of Contents
for Bioabsorbable Scaffolds - Current and Future Players

  • 1 Table of Contents

    1.1 List of Tables

    2 Introduction

    2.1 Catalyst

    2.2 Related Reports

    3 Competitive Assessment

    3.1 Overview

    3.2 Absorb BVS - Abbott Vascular

    3.2.1 Efficacy

    3.3 Remedy - Kyoto Medical Planning

    3.3.1 Efficacy

    3.4 DESolve - Elixir Medical Corperation

    3.4.1 Efficacy

    3.5 Pure - Arterial Remodeling Technologies

    3.5.1 Efficacy

    4 Pipeline Products

    4.1 Overview

    4.2 Coronary Artery Disease - Pipeline Products

    4.2.1 Overview

    4.2.2 Polymer-Based Bioabsorbable Scaffolds

    4.2.3 Metallic Bioabsorbable Scaffolds

    4.2.4 Summary

    4.3 Peripheral Artery Disease - Peripheral Bioabsorbable Scaffold Product Pipeline

    4.3.1 Overview

    4.3.2 Summary

    5 Current and Future Players

    5.1 Overview

    5.2 Trends in Corporate Strategy

    5.3 Company Profiles

    5.3.1 Abbott Vascular

    5.3.2 Kyoto Medical Planning Co., Ltd.

    5.3.3 Arterial Remodeling Technologies

    5.3.4 Elixir Medical Corporation

    5.3.5 Cardionovum

    5.3.6 Reva Medical

    5.3.7 OrbusNeich Medical

    5.3.8 Amaranth Medical

    5.3.9 Biotronik

    5.3.10 Lepu Medical Technology

    5.3.11 HuaAn Biotechnology Co., Ltd.

    5.3.12 Lifetech Scientific (Shenzhen) Co., LTD. (Lifetech Shenzhen)

    5.3.13 Arterius

    5.3.14 S3V Vascular Technologies

    5.3.15 Tepha Inc.

    5.3.16 Zorion Medical

    5.3.17 Xenogenics Corporation

    5.3.18 Meril Life Sciences

    5.3.19 Boston Scientific Corporation

    5.3.20 Icon Interventional Systems

    6 Appendix

    6.1 Bibliography

    6.2 Abbreviations

    6.3 Report Methodology

    6.3.1 Overview

    6.3.2 Coverage

    6.3.3 Primary Research -Key Opinion Leader Interviews

    6.3.4 Primary Research Interviews - Physician and Industry Participants

    6.3.5 Physician Survey

    6.3.6 Expert Panel Validation

    6.3.7 Secondary Research

    6.4 Forecasting Methodology

    6.5 Physicians and Specialists Included in This Study

    6.6 About the Authors

    6.6.1 Analysts

    6.6.2 James Coutcher, Global Head of Healthcare

    6.7 About GlobalData

    6.8 Contact Us

    6.9 Disclaimer

List Of Tables
in Bioabsorbable Scaffolds - Current and Future Players

1.1 List of Tables

Table 1: Marketed BAS Products

Table 2: Absorb BVS Product Profile

Table 3: Absorb BVS Clinical Trials

Table 4: Absorb BVS SWOT Analysis, 2015

Table 5: Remedy Product Profile

Table 6: Remedy SWOT Analysis, 2015

Table 7: DESolve Product Profile

Table 8: DESolve Clinical Trials

Table 9: DESolve SWOT Analysis, 2015

Table 10: Pure Product Profile

Table 11: Pure SWOT Analysis, 2015

Table 12: Coronary BAS Product Pipeline, 2015

Table 13: Igaki-Tamai Stent SWOT Analysis, 2015

Table 14: Fantom Scaffold SWOT Analysis, 2015

Table 15: ART18Z Scaffold SWOT Analysis, 2015

Table 16: Fortitude Scaffold SWOT Analysis, 2015

Table 17: ArterioSorb Scaffold SWOT Analysis, 2015

Table 18: Xinsorb Scaffold SWOT Analysis, 2015

Table 19: Ideal BioStent SWOT Analysis, 2015

Table 20: DREAMS Scaffold SWOT Analysis, 2015

Table 21: Peripheral BAS Product Pipeline, 2015

Table 22: Magic Explorer Scaffold SWOT Analysis, 2015

Table 23: ESPRIT BVS Stent SWOT Analysis, 2015

Table 24: Abbott Vascular Company Profile

Table 25: Marketed BAS Products by Abbott Vascular

Table 26: Pipeline BAS Products by Abbott Vascular

Table 27: Abbott Vascular SWOT Analysis, 2015

Table 28: Kyoto Medical Planning Company Profile

Table 29: Marketed BAS Products by Kyoto Medical Planning

Table 30: Pipeline BAS Products by Kyoto Medical Planning

Table 31: Kyoto Medical Planning SWOT Analysis, 2015

Table 32: ART Company Profile

Table 33: Marketed BAS Products by ART

Table 34: ART’s BAS Pipeline Products

Table 35: ART SWOT Analysis, 2015

Table 36: Elixir Medical Corporation Company Profile

Table 37: Marketed BAS Products by Elixir Medical

Table 38: Elixir Medical Corporation SWOT Analysis, 2015

Table 39: Cardionovum Company Profile

Table 40: Cardionovum’s BAS Pipeline Products

Table 41: Cardionovum SWOT Analysis, 2015

Table 42: REVA Medical’s BAS Pipeline Products

Table 43: REVA Medical SWOT Analysis, 2015

Table 44: OrbusNeich Medical Company Profile

Table 45: OrbusNeich Medical’s BAS Pipeline Products

Table 46: OrbusNeich Medical SWOT Analysis, 2015

Table 47: Amaranth Medical Company Profile

Table 48: Amaranth Medical’s BAS Pipeline Products

Table 49: Amaranth Medical SWOT Analysis, 2014

Table 50: Biotronik Company Profile

Table 51: Biotronik’s BAS Pipeline Products

Table 52: Biotronik SWOT Analysis, 2015

Table 53: Lepu Medical Technology Company Profile

Table 54: Lepu Medical Technology’s BAS Pipeline Products

Table 55: Lepu Medical Technology SWOT Analysis, 2015

Table 56: HuaAn Biotechnology Co., Ltd. Company Profile

Table 57: HuaAn Biomedical Co., Ltd.’s BAS Pipeline Products

Table 58: HuaAn Biomedical Co., Ltd. SWOT Analysis, 2015

Table 59: Lifetech Scientific Co., LTD Company Profile

Table 60: Lifetech Scientific’s BAS Pipeline Products

Table 61: Lifetech Scientific SWOT Analysis, 2015

Table 62: Arterius Company Profile

Table 63: Arterius BAS Pipeline Products

Table 64: Arterius SWOT Analysis, 2015

Table 65: S3V Vascular Technologies Company Profile

Table 66: S3V Vascular Technologies’ BAS Pipeline Product

Table 67: S3V Vascular Technologies SWOT Analysis, 2015

Table 68: Tepha Inc. Company Profile

Table 69: Tepha Inc.’s BAS Pipeline Product

Table 70: Tepha Inc. SWOT Analysis, 2015

Table 71: Zorion Medical Company Profile

Table 72: Zorion Medical’s BAS Pipeline Product

Table 73: Zorion Medical SWOT Analysis, 2015

Table 74: Xenogenics Corporation Company Profile

Table 75: Xenogenics Corporation’s BAS Pipeline Product

Table 76: Xenogenics Corporation SWOT Analysis, 2015

Table 77: Meril Life Sciences Company Profile

Table 78: Meril Life Science’s BAS Pipeline Product

Table 79: Meril Life Sciences SWOT Analysis, 2015

Table 80: Boston Scientific Corporation Company Profile

Table 81: Boston Scientific Corporation SWOT Analysis, 2015

Table 82: Icon Interventional Systems Company Profile

Table 83: Primary Research Interviews Completed

Table 84: Physicians Surveyed, By Country

Additional Details

Publisher

Global Data

Publisher Information

Reference

27811 | GDME1040FPR

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Bioabsorbable Stents Market Research Report Forecast 2017-2022
Delivery of the Report will take 48-72 hours once order is placed.The Global Bioabsorbable Stents M...
05 Jul 2017 by S&P Consulting USD $2,800 More Info
Coronary Stents Market by Product (Drug-eluting Stent, Bare-metal Stent, and Bioabsorbable Vascular Stent), Biomaterials {Metallic (Cobalt Chromium, Platinum Chromium, Nickel Chromium, and Stainless Steel), Polymeric, and Natural Biomaterials), End User (Hospital & Clinic and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Coronary stents are small expandable tubes that are used to treat narrowed or blocked coronary arter...
04 Apr 2017 by Allied Market Research USD $5,370 More Info
Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2016
Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical De...
01 Nov 2016 by Global Data USD $4,000 More Info
Bioabsorbable Stents Market by Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Global Forecast to 2021
The global bioabsorbable stents market is expected to reach USD 2.4 billion by 2021 from USD 0.4 bil...
16 Jun 2016 by MarketsandMarkets USD $5,650 More Info
Bioabsorbable Stents Market: By Material (Polymeric, Metallic); By Application (Coronary Artery Disease, Peripheral Artery Disease); By End- User (General Hospitals, Cardiac Centers, Surgical Centers) & By Geography-Forecast (2016-2021)
Stents are commonly used in the treatment of blocked arteries. Bioabsorbable stents are defined as f...
23 Feb 2016 by USD $5,250 More Info
Bioabsorbable Stents - Medical Devices Pipeline Assessment, 2015
Bioabsorbable Stents - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devices ...
01 Dec 2015 by Global Data USD $4,000 More Info
Bioabsorbable Scaffolds - US Analysis and Market Forecasts
Bioabsorbable Scaffolds - US Analysis and Market ForecastsSummaryCoronary artery disease (CAD) and p...
01 Aug 2015 by Global Data USD $4,450 More Info
Bioabsorbable Scaffolds - 5EU Analysis and Market Forecasts
Bioabsorbable Scaffolds - 5EU Analysis and Market ForecastsSummaryCoronary artery disease (CAD) and ...
01 Aug 2015 by Global Data USD $4,450 More Info
Bioabsorbable Scaffolds - APAC Analysis and Market Forecasts
Bioabsorbable Scaffolds - APAC Analysis and Market ForecastsSummaryCoronary artery disease (CAD) and...
01 Aug 2015 by Global Data USD $4,450 More Info
Bioabsorbable Scaffolds - South America Analysis and Market Forecasts
Bioabsorbable Scaffolds - South America Analysis and Market ForecastsSummaryCoronary artery disease ...
01 Aug 2015 by Global Data USD $4,450 More Info

This report is published by Global Data

Download Free Report Summary PDF

Bioabsorbable Scaffolds - Current and Future Players | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...